These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36860169)
1. Considerations for implementation of vancomycin Bayesian software monitoring in a level IV NICU population within a multisite health system. Oliver MB; Boeser KD; Carlson MK; Hansen LA Am J Health Syst Pharm; 2023 May; 80(11):670-677. PubMed ID: 36860169 [TBL] [Abstract][Full Text] [Related]
2. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis. Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162 [TBL] [Abstract][Full Text] [Related]
3. Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital. Frymoyer A; Schwenk HT; Zorn Y; Bio L; Moss JD; Chasmawala B; Faulkenberry J; Goswami S; Keizer RJ; Ghaskari S Front Pharmacol; 2020; 11():551. PubMed ID: 32411000 [TBL] [Abstract][Full Text] [Related]
4. Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients. Han J; Sauberan J; Tran MT; Adler-Shohet FC; Michalik DE; Tien TH; Tran L; DO DH; Bradley JS; Le J Ther Drug Monit; 2022 Apr; 44(2):241-252. PubMed ID: 34145165 [TBL] [Abstract][Full Text] [Related]
5. Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring. Chen A; Gupta A; Do DH; Nazer LH Pharmacol Res Perspect; 2022 Dec; 10(6):e01026. PubMed ID: 36398492 [TBL] [Abstract][Full Text] [Related]
6. Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin. Hughes JH; Tong DMH; Lucas SS; Faldasz JD; Goswami S; Keizer RJ Clin Pharmacol Ther; 2021 Jan; 109(1):233-242. PubMed ID: 33068298 [TBL] [Abstract][Full Text] [Related]
7. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study. Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the Implementation of AUC Dosing and Monitoring Practices With Vancomycin at Hospitals Across the United States. Bradley N; Lee Y; Sadeia M J Pharm Pract; 2022 Dec; 35(6):864-869. PubMed ID: 33902351 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Neonatal and Paediatric Vancomycin Pharmacokinetic Models and the Impact of Maturation and Serum Creatinine Covariates in a Large Multicentre Data Set. Hughes JH; Tong DMH; Faldasz JD; Frymoyer A; Keizer RJ Clin Pharmacokinet; 2023 Jan; 62(1):67-76. PubMed ID: 36404388 [TBL] [Abstract][Full Text] [Related]
10. Readiness to implement vancomycin monitoring based on area under the concentration-time curve: A cross-sectional survey of a national health consortium. Kufel WD; Seabury RW; Mogle BT; Beccari MV; Probst LA; Steele JM Am J Health Syst Pharm; 2019 Jun; 76(12):889-894. PubMed ID: 31063582 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981 [TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations. Reilly AM; Ding MX; Rower JE; Kiser TH J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury Incidence With Bayesian Dosing Software Versus 2-Level First-Order Area Under the Curve-Based Dosing of Vancomycin With Piperacillin-Tazobactam. Bellamy A; Covington EW J Pharm Technol; 2023 Aug; 39(4):183-190. PubMed ID: 37529152 [No Abstract] [Full Text] [Related]
15. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations. Aljutayli A; Thirion DJG; Bonnefois G; Nekka F Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243 [TBL] [Abstract][Full Text] [Related]
16. Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients. Turner RB; Kojiro K; Shephard EA; Won R; Chang E; Chan D; Elbarbry F Pharmacotherapy; 2018 Dec; 38(12):1174-1183. PubMed ID: 30362592 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle. Allegaert K; Flint R; Smits A Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708 [No Abstract] [Full Text] [Related]
18. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study. Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958 [TBL] [Abstract][Full Text] [Related]
19. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting. Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102 [TBL] [Abstract][Full Text] [Related]
20. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]